CD8+ T cell responses after superinfection and recombination
| Epitope . | Protein . | Sequence . | 22 d
(SFC/
Mio.) . | 419 d
(SFC/
Mio.) . | 1,160 da
(SFC/
Mio.) . |
|---|---|---|---|---|---|
| B27-KK10 | p24 | KRWIILGLNK | 85 | 830 | 250 |
| B27-VL9 | Vpr | VRHFPRIWL | - | 550 | 920 |
| B7-IL9 | gp41 | IPRRIRQGL | - | 480 | - |
| A2-AL9 | Vpr | AIIRILQQL | - | 310 | - |
| Cw1-CL9 | gp120 | CAPAGFAIL | - | 240 | 180 |
| B27-IK9 | p17 | IRLRPGGKK | - | 230 | 960 |
| Cw7-RY11 | Nef | RRQDILDLWIY | - | 160 | 70 |
| A1-YT9 | Nef | YFPDWQNYT | - | - | 1,440 |
| B7-RL9 | Nef | RPMTYKAAL | - | - | 1,330 |
| Cw1-VL8 | p24 | VIPMFSAL | - | - | 1,200 |
| B7-TL10 | Nef | TPGPGVRYPL | - | - | 1,070 |
| B7-RV9 | Nef | RPMTYKAAV | - | - | 1,040 |
| A2-SAV10 | gp41 | SLLNATAIAV | - | - | 980 |
| Epitope . | Protein . | Sequence . | 22 d
(SFC/
Mio.) . | 419 d
(SFC/
Mio.) . | 1,160 da
(SFC/
Mio.) . |
|---|---|---|---|---|---|
| B27-KK10 | p24 | KRWIILGLNK | 85 | 830 | 250 |
| B27-VL9 | Vpr | VRHFPRIWL | - | 550 | 920 |
| B7-IL9 | gp41 | IPRRIRQGL | - | 480 | - |
| A2-AL9 | Vpr | AIIRILQQL | - | 310 | - |
| Cw1-CL9 | gp120 | CAPAGFAIL | - | 240 | 180 |
| B27-IK9 | p17 | IRLRPGGKK | - | 230 | 960 |
| Cw7-RY11 | Nef | RRQDILDLWIY | - | 160 | 70 |
| A1-YT9 | Nef | YFPDWQNYT | - | - | 1,440 |
| B7-RL9 | Nef | RPMTYKAAL | - | - | 1,330 |
| Cw1-VL8 | p24 | VIPMFSAL | - | - | 1,200 |
| B7-TL10 | Nef | TPGPGVRYPL | - | - | 1,070 |
| B7-RV9 | Nef | RPMTYKAAV | - | - | 1,040 |
| A2-SAV10 | gp41 | SLLNATAIAV | - | - | 980 |
6 of the strongest responses, out of a total of 16 new responses developing after superinfection, are shown.